| 1 |
28347660 | Effect of genetic polymorphism on the inhibition of dopamine formation from p-tyramine catalyzed by brain cytochrome P450 2D6. | 2017 Apr 15 |
3 |
| 2 |
26657265 | CYP450 mediated inhibition potential of Swertia chirata: An herb from Indian traditional medicine. | 2016 Feb 3 |
1 |
| 3 |
25681130 | Guanfu base A, an antiarrhythmic alkaloid of Aconitum coreanum, Is a CYP2D6 inhibitor of human, monkey, and dog isoforms. | 2015 May |
1 |
| 4 |
26600643 | Interaction potential of Trigonella foenum graceum through cytochrome P450 mediated inhibition. | 2015 Sep-Oct |
1 |
| 5 |
16307862 | Characterization of the cytochrome P450 enzymes and enzyme kinetic parameters for metabolism of BVT.2938 using different in vitro systems. | 2006 Mar 18 |
1 |
| 6 |
14563706 | Cytochrome P450 2D catalyze steroid 21-hydroxylation in the brain. | 2004 Feb |
1 |
| 7 |
12502361 | Homology modeling of rat and human cytochrome P450 2D (CYP2D) isoforms and computational rationalization of experimental ligand-binding specificities. | 2003 Jan 2 |
1 |
| 8 |
9698290 | Cytochrome P4502D6 catalyzes the O-demethylation of the psychoactive alkaloid ibogaine to 12-hydroxyibogamine. | 1998 Aug |
1 |
| 9 |
1632813 | Metabolic activation of lidocaine and covalent binding to rat liver microsomal protein. | 1992 Jun 23 |
1 |
| 10 |
1763518 | Quinine is a more potent inhibitor than quinidine in rat of the oxidative metabolic routes of methoxyphenamine which involve debrisoquine 4-hydroxylase. | 1991 Nov |
1 |